Page 1054 - Clinical Immunology_ Principles and Practice ( PDFDrive )

CHaPter 75 Immunological Diseases of the Gastrointestinal Tract 1017

Cryptosporidium infectious diarrhea is seen, and sclerosing 9. Kivrak Salim D, Sahin M, Koksoy S, et al. Local Immune Response in
cholangitis, cirrhosis, and neoplasms of the hepatobiliary system Helicobacter pylori Infection. Medicine (Baltimore) 2016;95:e3713.
87
complicate the course in teenagers and young adults. Rarely, 10. Das S, Sarkar A, Ryan KA, et al. Brain angiogenesis inhibitor 1 is
noninfectious colitis has been reported. HSCT, preferably done expressed by gastric phagocytes during infection with Helicobacter pylori
before chronic complications occur, is the only approach with and mediates the recognition and engulfment of human apoptotic gastric
epithelial cells. FASEB J 2014;28:2214–24.
a potential for cure. X-linked lymphoproliferative syndrome 2 11. Kronsteiner B, Bassaganya-Riera J, Philipson C, et al. Systems-wide
(XIAP deficiency) can present with very early-onset fistulizing analyses of mucosal immune responses to Helicobacter pylori at the
perianal disease in up to 20% of patients. 88 interface between pathogenicity and symbiosis. Gut Microbes
Last, IPEX (immune dysfunction/polyendocrinopathy/ 2016;7:3–21.
enteropathy/X-linked) syndrome is interesting in that it results 12. Chey WD, Wong BC. American College of Gastroenterology guideline on
from a defect in FOXP3 expression and function, thereby inhibit- the management of Helicobacter pylori infection. Am J Gastroenterol
ing the generation of Tregs (Chapter 18). There is a lack of 2007;102:1808–25.
immune regulation, and enhanced responses, including autoim- 13. Marcus EA, Sachs G, Scott DR. Eradication of Helicobacter pylori
munity, occur. The gut mucosa is a major site affected by Infection. Curr Gastroenterol Rep 2016;18:33.
inflammation, and this complication presents with a watery, 14. Neumeister P, Troppan K, Raderer M. Management of gastric
mucosa-associated lymphoid tissue lymphoma. Dig Dis 2015;33:11–18.
sometimes bloody, diarrhea and malabsorption. Biopsies show 15. Fasano A. Systemic autoimmune disorders in celiac disease. Curr Opin
villus blunting and atrophy in the small bowel and increased Gastroenterol 2006;22:674–9.
intraepithelial lymphocytes, lamina propria infiltration with T 16. Abadie V, Sollid LM, Barreiro LB, et al. Integration of genetic and
89
cells, eosinophils, and neutrophils elsewhere in the gut. Treatment immunological insights into a model of celiac disease pathogenesis. Annu
requires HSCT, but the gut disease may be managed temporarily Rev Immunol 2011;29:493–525.
with corticosteroids and immunosuppressants. Of note, one of 17. Caminero A, Galipeau HJ, McCarville JL, et al. Duodenal bacteria from
the side effects of the anti– cytotoxic T lymphocyte antigen-4 patients with celiac disease and healthy subjects distinctly affect gluten
(CTLA-4) antibody ipilimumab, given to augment a T-cell breakdown and immunogenicity. Gastroenterology 2016;151:670–83.
response against solid tumors, is a colitis that can have penetrating 18. Tang F, Sally B, Lesko K, et al. Cysteinyl leukotrienes mediate lymphokine
ulcers; this unexpected side effect points to the importance of killer activity induced by NKG2D and IL-15 in cytotoxic T cells during
celiac disease. J Exp Med 2015;212:1487–95.
regulatory mechanisms for gut immune homeostasis. 90 19. Castellanos-Rubio A, Fernandez-Jimenez N, Kratchmarov R, et al. A long
noncoding RNA associated with susceptibility to celiac disease. Science
On tHe HOrIZOn 2016;352:91–5.
20. Castillo NE, Vanga RR, Theethira TG, et al. Prevalence of abnormal liver
Primary Immunodeficiency Diseases function tests in celiac disease and the effect of a gluten-free diet in the
Translation of monogenic immunodeficiency disease mechanisms, US population. Am J Gastroenterol 2015;110:1216–22.
especially in very-early-onset inflammatory bowel disease (IBD), into 21. Adriaanse M, Leffler DA. Serum markers in the clinical management of
knowledge of pathophysiology (genetic and acquired) of Crohn disease celiac disease. Dig Dis 2015;33:236–43.
and ulcerative colitis for novel drug development 22. Troncone R, Jabri B. Coeliac disease and gluten sensitivity. J Intern Med
2011;269:582–90.
23. Uhde M, Ajamian M, Caio G, et al. Intestinal cell damage and systemic
immune activation in individuals reporting sensitivity to wheat in the
Please check your eBook at https://expertconsult.inkling.com/ absence of coeliac disease. Gut 2016;65:1930–7.
for self-assessment questions. See inside cover for registration 24. van Gils T, Nijeboer P, van Wanrooij RL, et al. Mechanisms and
details. management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol
2015;12:572–9.
25. Fiocchi C. Inflammatory bowel disease pathogenesis: where are we?
REFERENCES J Gastroenterol Hepatol 2015;30:12–18.
26. Hou JK, El-Serag H, Thirumurthi S. Distribution and manifestations of
1. Neumann WL, Coss E, Rugge M, et al. Autoimmune atrophic gastritis— inflammatory bowel disease in Asians, Hispanics, and African Americans:
pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol a systematic review. Am J Gastroenterol 2009;104:2100–9.
2013;10:529–41. 27. Mahid SS, Mulhall AM, Gholson RD, et al. Inflammatory bowel disease
2. Lahner E, Norman GL, Severi C, et al. Reassessment of intrinsic factor and African Americans: a systematic review. Inflamm Bowel Dis
and parietal cell autoantibodies in atrophic gastritis with respect to 2008;14:960–7.
cobalamin deficiency. Am J Gastroenterol 2009;104:2071–9. 28. Cho JH, Brant SR. Recent insights into the genetics of inflammatory
3. Negrini R, Savio A, Poiesi C, et al. Antigenic mimicry between bowel disease. Gastroenterology 2011;140:1704–12.
Helicobacter pylori and gastric mucosa in the pathogenesis of body 29. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior
atrophic gastritis. Gastroenterology 1996;111:655–65. of Crohn’s disease. Inflamm Bowel Dis 2002;8:244–50.
4. Amedei A, Bergman MP, Appelmelk BJ, et al. Molecular mimicry between 30. Uhlig HH, McKenzie BS, Hue S, et al. Differential activity of IL-12 and
Helicobacter pylori antigens and H+, K+ –adenosine triphosphatase in IL-23 in mucosal and systemic innate immune pathology. Immunity
human gastric autoimmunity. J Exp Med 2003;198:1147–56. 2006;25:309–18.
5. Ernst PB, Peura DA, Crowe SE. The translation of Helicobacter pylori 31. Yen D, Cheung J, Scheerens H, et al. IL-23 is essential for T cell-mediated
basic research to patient care. Gastroenterology 2006;130:188–206, quiz colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest
12–3. 2006;116:1310–16.
6. Egan BJ, Holmes K, O’Connor HJ, et al. Helicobacter pylori gastritis, the 32. Powrie F, Leach MW, Mauze S, et al. Inhibition of Th1 responses prevents
unifying concept for gastric diseases. Helicobacter 2007;12:39–44. inflammatory bowel disease in SCID mice reconstituted with CD45RBhi
7. Sepulveda AR, Patil M. Practical approach to the pathologic diagnosis of CD4+ T cells. Immunity 1994;1:553–62.
gastritis. Arch Pathol Lab Med 2008;132:1586–93. 33. Fuss IJ, Becker C, Yang Z, et al. Both IL-12p70 and IL-23 are synthesized
8. Hunt RH, Camilleri M, Crowe SE, et al. The stomach in health and during active Crohn’s disease and are down-regulated by treatment with
disease. Gut 2015;64:1650–68. anti-IL-12 p40 monoclonal antibody. Inflamm Bowel Dis 2006;12:9–15.